Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,777 total articles

Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion

Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion

Aura Biosciences announced the appointment of Natalie Holles as CEO and President, coinciding with the nearing completion of patient enrollment in its pivotal Phase 3 CoMpass trial for belzupacap sarotalocan (bel-sar), a potential first frontline, vision-preserving therapy for early choroidal melanoma. The company maintains guidance for enrollment …

KBR Mission Technology Solutions Awarded $449 Million Army LOGCAP Extension in Europe and North America

KBR Mission Technology Solutions Awarded $449 Million Army LOGCAP Extension in Europe and North America

KBR Inc. announced that its Mission Technology Solutions division received two task order modifications totaling $449 million under the U.S. Army's Logistics Civil Augmentation Program (LOGCAP) V. The awards include a $304 million contract for logistics and mission-critical infrastructure support in Europe and a $145 million contract for maintenanc…

Auddia Introduces Voyex as Stranded Spirit Airlines Passengers Highlight Urgent Need for Agentic AI Rebooking Infrastructure

Auddia Introduces Voyex as Stranded Spirit Airlines Passengers Highlight Urgent Need for Agentic AI Rebooking Infrastructure

Auddia Inc. (NASDAQ: AUUD) announced its merger with Thramann Holdings to create McCarthy Finney (NASDAQ: MCFN), an AI-native holding company encompassing four subsidiaries including Voyex, which is developing FlightFix, an agentic AI-powered platform designed to automate and modernize recovery from airline travel disruptions. The recent Spirit Air…

Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences

Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences

Molecular Partners AG announced upcoming oral presentations highlighting their lead Radio-DARPin candidate MP0712, a targeted radiotherapy for small cell lung cancer (SCLC), at several key scientific conferences. The presentations will cover molecular characteristics, preclinical to clinical advancements, and first-in-human insights, demonstrating …

Okeanis Eco Tankers Corp.

Okeanis Eco Tankers Corp.

Okeanis Eco Tankers Corp. announced new financing agreements totaling $190 million to fund the acquisition of two new Suezmax vessels under construction and to repurchase two vessels from sale and leaseback arrangements. The new debt facilities, backed by prominent Taiwanese and Greek banks, offer improved interest margins and extended maturities, …

Bath & Body Works launches an out-of-this-galaxy collection to celebrate the release of Star Wars: The Mandalorian and Grogu, only in theaters May 22

Bath & Body Works launches an out-of-this-galaxy collection to celebrate the release of Star Wars: The Mandalorian and Grogu, only in theaters May 22

Bath & Body Works launches a limited-edition Star Wars: The Mandalorian and Grogu collection featuring three original fragrances and related body care and home products. Available from May 4 for rewards members and May 11 for all customers in US and Canada, the collection celebrates the upcoming film release on May 22 and will expand internationall…

Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

Celcuity Inc. announced positive topline results from the PIK3CA mutant cohort in their Phase 3 VIKTORIA-1 clinical trial evaluating gedatolisib combined with fulvestrant and palbociclib in hormone receptor positive, HER2-negative advanced breast cancer. The trial demonstrated statistically significant and clinically meaningful improvements in prog…

Northrop Grumman Honors Top Suppliers Driving Industrial Innovation

Northrop Grumman Honors Top Suppliers Driving Industrial Innovation

Northrop Grumman Corporation honored over 30 domestic and international suppliers with its Supplier Excellence Awards for their critical role in advancing defense capabilities, including autonomous systems, AI analytics, and secure cloud infrastructure. The company emphasized strong partnerships and continuous investment in U.S. manufacturing infra…